Tag: ATC 2022
Machine learning fails to outperform traditional models in predicting long-term allograft...
A study presented at this year’s American Transplant Congress (ATC; 4–8 June, Boston, USA) found that machine learning (ML) technologies did not outperform traditional...
AlloVir reports preliminary data on posoleucel for BK viraemia in kidney...
AlloVir has announced preliminary, blinded data from an ongoing Phase 2 study of posoleucel—an investigational, allogeneic, off-the-shelf, multi-virus-specific T cell (VST) therapy for the...
CareDx expands portfolio with new AI-based tool for predicting kidney allograft...
CareDx recently announced that it plans to expand its growing multimodality portfolio with AiKidney—a new clinical decision support tool for allograft risk assessment that...
Natera showcases new data on Prospera and Renasight tests at American...
Natera today announced the presentation of data on the clinical utility of its Prospera and Renasight tests across a total of 14 sessions at...